{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:19:15Z","timestamp":1706573955547},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00105-023-05273-9","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:02:23Z","timestamp":1704798143000},"page":"153-162","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aktuelle Aspekte zur Dermatomyositis","Current update on dermatomyositis"],"prefix":"10.1007","volume":"75","author":[{"given":"Julian","family":"Steininger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"5273_CR1","unstructured":"Wiendl H., Schmidt J. et\u00a0al., Myositissyndrome, S2k-Leitlinie, 2022; in: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Online: www.dgn.org\/leitlinien (abgerufen am 2. Aug. 2023)."},{"issue":"18","key":"5273_CR2","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas\u00a0MC (2015) Inflammatory muscle diseases. N\u00a0Engl J Med 372(18):1734\u20131747","journal-title":"N Engl J Med"},{"issue":"1","key":"5273_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","volume":"77","author":"JB Lilleker","year":"2018","unstructured":"Lilleker\u00a0JB, Vencovsky\u00a0J, Wang\u00a0G, Wedderburn\u00a0LR, Diederichsen\u00a0LP, Schmidt\u00a0J et\u00a0al (2018) The euromyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30\u201339","journal-title":"Ann Rheum Dis"},{"key":"5273_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","volume":"8","author":"A Aussy","year":"2017","unstructured":"Aussy\u00a0A, Boyer\u00a0O, Cordel\u00a0N (2017) Dermatomyositis and immune-mediated necrotizing myopathies: a\u00a0window on autoimmunity and cancer. Front Immunol 8:992","journal-title":"Front Immunol"},{"issue":"5","key":"5273_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst\u00a0DE, Amato\u00a0AA, Iorga \u015eR, Gajria\u00a0K, Fernandes\u00a0AW (2012) Epidemiology of adult idiopathic inflammatory myopathies in a\u00a0U.S. managed care plan. Muscle Nerve 45(5):676\u2013683","journal-title":"Muscle Nerve"},{"issue":"1","key":"5273_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald\u00a0MJ, Wetter\u00a0DA, Li\u00a0X, Davis\u00a0MDP (2010) Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a\u00a0population-based study in olmsted county, minnesota. Arch Dermatol 146(1):26\u201330","journal-title":"Arch Dermatol"},{"issue":"3","key":"5273_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"15;49","author":"EP Mendez","year":"2003","unstructured":"Mendez\u00a0EP, Lipton\u00a0R, Ramsey-Goldman\u00a0R, Roettcher\u00a0P, Bowyer\u00a0S, Dyer\u00a0A et\u00a0al (2003) US incidence of juvenile dermatomyositis, 1995\u20131998: results from the national institute of arthritis and musculoskeletal and skin diseases registry. Arthritis Rheum 15;49(3):300\u2013305","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5273_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/BOR.0b013e3283585748","volume":"24","author":"LC Zaba","year":"2012","unstructured":"Zaba\u00a0LC, Fiorentino\u00a0DF (2012) Skin disease in dermatomyositis. Curr Opin Rheumatol 24(6):597\u2013601","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"5273_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1600-0714.2004.00280.x","volume":"34","author":"K M\u00e1rton","year":"2005","unstructured":"M\u00e1rton\u00a0K, Hermann\u00a0P, Dank\u00f3\u00a0K, Fej\u00e9rdy\u00a0P, Madl\u00e9na\u00a0M, Nagy\u00a0G (2005) Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis. J\u00a0Oral Pathol Med 34(3):164\u2013169","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"5273_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10067-014-2795-8","volume":"34","author":"A Manfredi","year":"2015","unstructured":"Manfredi\u00a0A, Sebastiani\u00a0M, Cassone\u00a0G, Pipitone\u00a0N, Giuggioli\u00a0D, Colaci\u00a0M et\u00a0al (2015) Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol 34(2):279\u2013284","journal-title":"Clin Rheumatol"},{"issue":"5","key":"5273_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.21037\/atm-20-5175","volume":"9","author":"LM Hodgkinson","year":"2021","unstructured":"Hodgkinson\u00a0LM, Wu\u00a0TT, Fiorentino\u00a0DF (2021) Dermatomyositis autoantibodies: how can we maximize utility? Ann Transl Med 9(5):433","journal-title":"Ann Transl Med"},{"issue":"2","key":"5273_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","volume":"18","author":"IN Targoff","year":"1992","unstructured":"Targoff\u00a0IN (1992) Autoantibodies in polymyositis. Rheum Dis Clin North Am 18(2):455\u2013482","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"5273_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane\u00a0ME, Waldman\u00a0R, Lu\u00a0J (2020) Dermatomyositis: clinical features and pathogenesis. J\u00a0Am Acad Dermatol 82(2):267\u2013281","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"5273_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino\u00a0D, Chung\u00a0L, Zwerner\u00a0J, Rosen\u00a0A, Casciola-Rosen\u00a0L (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a\u00a0retrospective study. J\u00a0Am Acad Dermatol 65(1):25\u201334","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"5273_CR15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono\u00a0T, Kawaguchi\u00a0Y, Satoh\u00a0T, Kuwana\u00a0M, Katsumata\u00a0Y, Takagi\u00a0K et\u00a0al (2010) Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a\u00a0complication of dermatomyositis. Rheumatol (Oxford) 49(9):1713\u20131719","journal-title":"Rheumatol (Oxford)"},{"issue":"6","key":"5273_CR16","first-page":"891","volume":"32","author":"A Ceribelli","year":"2014","unstructured":"Ceribelli\u00a0A, Fredi\u00a0M, Taraborelli\u00a0M, Cavazzana\u00a0I, Tincani\u00a0A, Selmi\u00a0C et\u00a0al (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis. Clin Exp Rheumatol 32(6):891\u2013897","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"5273_CR17","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/acr.23210","volume":"69","author":"A Rogers","year":"2017","unstructured":"Rogers\u00a0A, Chung\u00a0L, Li\u00a0S, Livia-Casciola-Rosen, Fiorentino\u00a0DF (2017) The cutaneous and systemic findings associated with nuclear matrix protein\u20112 antibodies in adult dermatomyositis patients. Arthritis Care Res (Hoboken) 69(12):1909\u20131914","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"5273_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MGP Cruellas","year":"2013","unstructured":"Cruellas\u00a0MGP, Viana V dos\u00a0ST, Levy-Neto\u00a0M, de Souza\u00a0FHC, Shinjo\u00a0SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a\u00a0large series of patients with polymyositis and dermatomyositis. Clin (Sao Paulo) 68(7):909\u2013914","journal-title":"Clin (Sao Paulo)"},{"issue":"2","key":"5273_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bjd.15468","volume":"177","author":"S Meisterfeld","year":"2017","unstructured":"Meisterfeld\u00a0S, R\u00f6ber\u00a0N, Conrad\u00a0K, Beissert\u00a0S, Aringer\u00a0M, G\u00fcnther\u00a0C (2017) A\u00a0chronic recurrent disease course of dermatomyositis is associated with autoantibodies against transcriptional intermediary factor\u00a01\u2011\u03b3. Br J Dermatol 177(2):590\u2013593","journal-title":"Br J Dermatol"},{"issue":"9250","key":"5273_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill\u00a0CL, Zhang\u00a0Y, Sigurgeirsson\u00a0B, Pukkala\u00a0E, Mellemkjaer\u00a0L, Airio\u00a0A et\u00a0al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a\u00a0population-based study. Lancet 357(9250):96\u2013100","journal-title":"Lancet"},{"issue":"5","key":"5273_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","volume":"88","author":"A Uruha","year":"2017","unstructured":"Uruha\u00a0A, Nishikawa\u00a0A, Tsuburaya\u00a0RS, Hamanaka\u00a0K, Kuwana\u00a0M, Watanabe\u00a0Y et\u00a0al (2017) Sarcoplasmic MxA expression: a\u00a0valuable marker of dermatomyositis. Neurology 88(5):493\u2013500","journal-title":"Neurology"},{"issue":"7","key":"5273_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","volume":"16","author":"S Suzuki","year":"2017","unstructured":"Suzuki\u00a0S, Uruha\u00a0A, Suzuki\u00a0N, Nishino\u00a0I (2017) Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology. Autoimmun Rev 16(7):693\u2013700","journal-title":"Autoimmun Rev"},{"issue":"8","key":"5273_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","volume":"75","author":"S Rothwell","year":"2016","unstructured":"Rothwell\u00a0S, Cooper\u00a0RG, Lundberg\u00a0IE, Miller\u00a0FW, Gregersen\u00a0PK, Bowes\u00a0J et\u00a0al (2016) Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis 75(8):1558\u20131566","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"5273_CR24","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.24702","volume":"60","author":"LA Love","year":"2009","unstructured":"Love\u00a0LA, Weinberg\u00a0CR, McConnaughey\u00a0DR, Oddis\u00a0CV, Medsger\u00a0TA, Reveille\u00a0JD et\u00a0al (2009) Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi\u20112 autoantibodies in women. Arthritis Rheum 60(8):2499\u20132504","journal-title":"Arthritis Rheum"},{"issue":"11","key":"5273_CR25","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/art.1780291109","volume":"29","author":"ML Christensen","year":"1986","unstructured":"Christensen\u00a0ML, Pachman\u00a0LM, Schneiderman\u00a0R, Patel\u00a0DC, Friedman\u00a0JM (1986) Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29(11):1365\u20131370","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5273_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel\u00a0JT, Mendell\u00a0JR, Rammohan\u00a0KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N\u00a0Engl J Med 314(6):329\u2013334","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"5273_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","volume":"13","author":"EC Baechler","year":"2007","unstructured":"Baechler\u00a0EC, Bauer\u00a0JW, Slattery\u00a0CA, Ortmann\u00a0WA, Espe\u00a0KJ, Novitzke\u00a0J et\u00a0al (2007) An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13(1\u20132):59\u201368","journal-title":"Mol Med"},{"issue":"5","key":"5273_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg\u00a0SA, Pinkus\u00a0JL, Pinkus\u00a0GS, Burleson\u00a0T, Sanoudou\u00a0D, Tawil\u00a0R et\u00a0al (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57(5):664\u2013678","journal-title":"Ann Neurol"},{"issue":"5","key":"5273_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/ard.2010.139949","volume":"70","author":"AP Liao","year":"2011","unstructured":"Liao\u00a0AP, Salajegheh\u00a0M, Nazareno\u00a0R, Kagan\u00a0JC, Jubin\u00a0RG, Greenberg\u00a0SA (2011) Interferon\u00a0\u03b2 is associated with type\u00a01 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis 70(5):831\u2013836","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5273_CR30","doi-asserted-by":"publisher","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","volume":"7","author":"D Wong","year":"2012","unstructured":"Wong\u00a0D, Kea\u00a0B, Pesich\u00a0R, Higgs\u00a0BW, Zhu\u00a0W, Brown\u00a0P et\u00a0al (2012) Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases. Plos One 7(1):e29161","journal-title":"Plos One"},{"issue":"4","key":"5273_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1517\/14740330903066726","volume":"8","author":"LM Burdick","year":"2009","unstructured":"Burdick\u00a0LM, Somani\u00a0N, Somani\u00a0AK (2009) Type\u00a0I IFNs and their role in the development of autoimmune diseases. Expert Opin Drug Saf 8(4):459\u2013472","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"5273_CR32","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.jid.2020.12.032","volume":"141","author":"KL Chen","year":"2021","unstructured":"Chen\u00a0KL, Patel\u00a0J, Zeidi\u00a0M, Wysocka\u00a0M, Bashir\u00a0MM, Patel\u00a0B et\u00a0al (2021) Myeloid dendritic cells are major producers of IFN\u2011\u03b2 in dermatomyositis and may contribute to hydroxychloroquine refractoriness. J\u00a0Invest Dermatol 141(8):1906\u20131914.e2","journal-title":"J Invest Dermatol"},{"issue":"5","key":"5273_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","volume":"35","author":"JM McNiff","year":"2008","unstructured":"McNiff\u00a0JM, Kaplan\u00a0DH (2008) Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a\u00a0pattern distinct from lupus erythematosus. J\u00a0Cutan Pathol 35(5):452\u2013456","journal-title":"J Cutan Pathol"},{"issue":"8","key":"5273_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2022","unstructured":"Crow\u00a0YJ, Stetson\u00a0DB (2022) The type\u00a0I interferonopathies: 10\u00a0years on. Nat Rev Immunol 22(8):471\u2013483","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"5273_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jdv.13516","volume":"30","author":"V Vuong","year":"2016","unstructured":"Vuong\u00a0V, Duong\u00a0TA, Aouizerate\u00a0J, Authier\u00a0FJ, Ingen-Housz-Oro\u00a0S, Valeyrie-Allanore\u00a0L et\u00a0al (2016) Dermatomyositis: factors predicting relapse. J\u00a0Eur Acad Dermatol Venereol 30(5):813\u2013818","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5273_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3389\/fimmu.2017.01679","volume":"8","author":"M Efremova","year":"2017","unstructured":"Efremova\u00a0M, Finotello\u00a0F, Rieder\u00a0D, Trajanoski\u00a0Z (2017) Neoantigens generated by individual mutations and their role in cancer immunity and immunotherapy. Front Immunol 8:1679","journal-title":"Front Immunol"},{"key":"5273_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-immunol-032414-112205","volume":"20;34","author":"A Rosen","year":"2016","unstructured":"Rosen\u00a0A, Casciola-Rosen\u00a0L (2016) Autoantigens as partners in initiation and propagation of autoimmune rheumatic diseases. Annu Rev Immunol 20;34:395\u2013420","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"5273_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/art.38863","volume":"67","author":"P Mohassel","year":"2015","unstructured":"Mohassel\u00a0P, Rosen\u00a0P, Casciola-Rosen\u00a0L, Pak\u00a0K, Mammen\u00a0AL (2015) Expression of the dermatomyositis autoantigen transcription intermediary factor\u00a01\u03b3 in regenerating muscle. Arthritis Rheumatol 67(1):266\u2013272","journal-title":"Arthritis Rheumatol"},{"key":"5273_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn\u00a0GP, Old\u00a0LJ, Schreiber\u00a0RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329\u2013360","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"5273_CR40","doi-asserted-by":"publisher","first-page":"e150201","DOI":"10.1172\/JCI150201","volume":"132","author":"DF Fiorentino","year":"2022","unstructured":"Fiorentino\u00a0DF, Mecoli\u00a0CA, Rosen\u00a0MC, Chung\u00a0LS, Christopher-Stine\u00a0L, Rosen\u00a0A et\u00a0al (2022) Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence. J\u00a0Clin Invest 132(2):e150201","journal-title":"J Clin Invest"},{"issue":"4","key":"5273_CR41","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1093\/rheumatology\/keaa657","volume":"60","author":"A Heinen","year":"2021","unstructured":"Heinen\u00a0A, Schnabel\u00a0A, Br\u00fcck\u00a0N, Smitka\u00a0M, Wolf\u00a0C, Lucas\u00a0N et\u00a0al (2021) Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis? Rheumatol (Oxford) 60(4):e136\u2013e138","journal-title":"Rheumatol (Oxford)"},{"issue":"3","key":"5273_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/bjd.21252","volume":"187","author":"K Fischer","year":"2022","unstructured":"Fischer\u00a0K, Aringer\u00a0M, Steininger\u00a0J, Heil\u00a0J, Beissert\u00a0S, Abraham\u00a0S et\u00a0al (2022) Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the janus kinase inhibitor baricitinib. Br J Dermatol 187(3):432\u2013435","journal-title":"Br J Dermatol"},{"issue":"1","key":"5273_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","volume":"73","author":"BW Higgs","year":"2014","unstructured":"Higgs\u00a0BW, Zhu\u00a0W, Morehouse\u00a0C, White\u00a0WI, Brohawn\u00a0P, Guo\u00a0X et\u00a0al (2014) A\u00a0phase\u00a01b clinical trial evaluating sifalimumab, an anti-IFN\u2011\u03b1 monoclonal antibody, shows target neutralisation of a\u00a0type\u00a0I IFN signature in blood of dermatomyositis and polymyositis patients. Ann Rheum Dis 73(1):256\u2013262","journal-title":"Ann Rheum Dis"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05273-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T19:03:50Z","timestamp":1706555030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05273-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["5273"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05273-9","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"20 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>J.\u00a0Steininger<\/b>: A.\u00a0Finanzielle Interessen: J.\u00a0Steininger gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt f\u00fcr Dermatologie, Klinik und Poliklinik f\u00fcr Dermatologie, Universit\u00e4tsklinikum Carl Gustav Carus Dresden | Mitgliedschaften: DDG, Society for Nucleic Acid Immunity. <b>C.\u00a0G\u00fcnther<\/b>: A.\u00a0Finanzielle Interessen: C.\u00a0G\u00fcnther ist an klinischen Studien zur Dermatomyositis beteiligt (Firma: Bristol-Myers Squibb) und erhielt eine F\u00f6rderung durch die Deutsche Forschungsgemeinschaft TRR237 369799452\/404458960\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Professorin f\u00fcr Dermato-Immunologie UKD, TU Dresden, Deutschland\u00a0| Mitgliedschaften: DDG, ADF, DNSS, Society for Nucleic Acid Immunity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}